Bollard Group’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90K | Hold |
55,555
| – | – | ﹤0.01% | 204 |
|
|
2025
Q1 | $40K | Hold |
55,555
| – | – | ﹤0.01% | 224 |
|
|
2024
Q4 | $62K | Hold |
55,555
| – | – | ﹤0.01% | 211 |
|
|
2024
Q3 | $39K | Hold |
55,555
| – | – | ﹤0.01% | 243 |
|
|
2024
Q2 | $56K | Hold |
55,555
| – | – | ﹤0.01% | 229 |
|
|
2024
Q1 | $132K | Hold |
55,555
| – | – | ﹤0.01% | 182 |
|
|
2023
Q4 | $125K | Hold |
55,555
| – | – | ﹤0.01% | 181 |
|
|
2023
Q3 | $118K | Hold |
55,555
| – | – | ﹤0.01% | 177 |
|
|
2023
Q2 | $172K | Hold |
55,555
| – | – | 0.01% | 170 |
|
|
2023
Q1 | $299K | Hold |
55,555
| – | – | 0.01% | 149 |
|
|
2022
Q4 | $369K | Hold |
55,555
| – | – | 0.01% | 133 |
|
|
2022
Q3 | $221K | Hold |
55,555
| – | – | 0.01% | 160 |
|
|
2022
Q2 | $276K | Hold |
55,555
| – | – | 0.01% | 162 |
|
|
2022
Q1 | $336K | Hold |
55,555
| – | – | 0.01% | 192 |
|
|
2021
Q4 | $646K | Hold |
55,555
| – | – | 0.02% | 157 |
|
|
2021
Q3 | $871K | Hold |
55,555
| – | – | 0.03% | 141 |
|
|
2021
Q2 | $1.04M | Hold |
55,555
| – | – | 0.03% | 127 |
|
|
2021
Q1 | $2.39M | Buy |
+55,555
| New | +$2.39M | 0.08% | 93 |
|